Global Biosimilars Market Worth USD 25 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Vendors: Amgen, Biocad, Celltrion - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis" report to their offering.

The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020.

With the continuous increasing demand for biologics, manufacturers are looking for novel strategies that will help them attain maximum returns on investment. Biosimilars are seen as the key weapon to curbing soaring healthcare costs globally.

The lower cost of these drugs as compared to the patented biologics, the increasing encumbrance to curb healthcare costs globally, increasing nationwide government initiatives, and the strong pipeline for the biosimilar drugs is expected to fuel the biosimilars industry.

This 177 Page report with 74 Figures and 27 Tables is analyzed from 6 viewpoints:

  • 1. Global Biosimilars Market and Forecast - By Product Type
  • 2. Global Biosimilars Market and Forecast - By Applications
  • 3. Global Biosimilars Market and Forecast - By Country Wise
  • 4. Global Biosimilars Company - Profile, Revenue, Approved and Pipeline Biosimilars Analysis
  • 5. Country with Biosimilar Guideline and Published Year
  • 6. Global Biosimilars Market - Driving Factors and Challenges

Companies Mentioned:

  • Amgen Inc.
  • Biocad
  • Biocon
  • Celltrion Inc.
  • Dong-A Socio Group
  • Dr. Reddy's Laboratories
  • Intas Pharmaceuticals Ltd.
  • Merck KGaA
  • Mylan
  • Pfizer Inc.
  • Sandoz International GmbH - A Novartis Company
  • Stada Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd

Report Structure:

1. Executive Summary

2. Global Biosimilars Market and Forecast to 2021

3. Global Biosimilars Market Share and Forecast to 2021

4. Global Biosimilars Market and Forecast - By Product Type

5. Global Biosimilars Market and Forecast - By Applications

6. Global Biosimilars Market and Forecast - By Country Wise

7. Global Biosimilars Company - Profile, Revenue, Approved and Pipeline Biosimilars Analysis

8. Biosimilars Approved in Europe

9. Country with Biosimilar Guideline and Published Year

10. Global Biosimilars Market - Driving Factors

11. Global Biosimilars Market - Challenges

For more information about this report visit http://www.researchandmarkets.com/research/4rjgr6/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biosimilars and Biosuperiors

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biosimilars and Biosuperiors